Multi-targeted 1H/19F MRI unmasks specific danger patterns for emerging cardiovascular disorders.
Ulrich FlögelSebastian TemmeChristoph JacobyThomas OertherPetra KeulVera FlockeXiaowei WangFlorian BönnerFabian NienhausKarlheinz PeterJürgen SchraderMaria GrandochMalte KelmBodo LevkauPublished in: Nature communications (2021)
Prediction of the transition from stable to acute coronary syndromes driven by vascular inflammation, thrombosis with subsequent microembolization, and vessel occlusion leading to irreversible myocardial damage is still an unsolved problem. Here, we introduce a multi-targeted and multi-color nanotracer platform technology that simultaneously visualizes evolving danger patterns in the development of progressive coronary inflammation and atherothrombosis prior to spontaneous myocardial infarction in mice. Individual ligand-equipped perfluorocarbon nanoemulsions are used as targeting agents and are differentiated by their specific spectral signatures via implementation of multi chemical shift selective 19F MRI. Thereby, we are able to identify areas at high risk of and predictive for consecutive development of myocardial infarction, at a time when no conventional parameter indicates any imminent danger. The principle of this multi-targeted approach can easily be adapted to monitor also a variety of other disease entities and constitutes a technology with disease-predictive potential.
Keyphrases
- cancer therapy
- oxidative stress
- left ventricular
- heart failure
- magnetic resonance imaging
- acute coronary syndrome
- coronary artery disease
- healthcare
- coronary artery
- contrast enhanced
- multiple sclerosis
- primary care
- percutaneous coronary intervention
- high throughput
- single cell
- antiplatelet therapy
- pulmonary embolism
- computed tomography
- diffusion weighted imaging
- magnetic resonance
- risk assessment
- human health
- insulin resistance
- adipose tissue